Key result
Cardiac-specific up-regulation of calreticulin in adult mice induced dilated cardiomyopathy, significantly reducing left ventricular ejection fraction to 30.8% compared to 64.5% in controls.
Why the study?
Does up-regulated expression of calreticulin induce cardiomyopathy in adult mice?
Does up-regulated expression of calreticulin induce cardiomyopathy in adult mice?
Up-regulation of the endoplasmic reticulum chaperone calreticulin in the adult heart induces dilated cardiomyopathy and heart failure by altering Ca2+ handling proteins and gap junctions.
Answers are grounded in this paper and cite their sources.
Supports calreticulin up-regulation as a driver of adult cardiomyopathy; leaves open human translation and therapeutic targeting.
BACKGROUND: Calreticulin, a Ca(2+)-buffering chaperone of the endoplasmic reticulum, is highly expressed in the embryonic heart and is essential for cardiac development. After birth, the calreticulin gene is sharply down regulated in the heart, and thus, adult hearts have negligible levels of calreticulin. In this study we tested the role of calreticulin in the adult heart. METHODOLOGY/PRINCIPAL FINDINGS: We generated an inducible transgenic mouse in which calreticulin is targeted to the cardiac tissue using a Cre/loxP system and can be up-regulated in adult hearts. Echocardiography analysis of hearts from transgenic mice expressing calreticulin revealed impaired left ventricular systolic and diastolic function and impaired mitral valve function. There was altered expression of Ca(2+) signaling molecules and the gap junction proteins, Connexin 43 and 45. Sarcoplasmic reticulum associated Ca(2+)-handling proteins (including the cardiac ryanodine receptor, sarco/endoplasmic reticulum Ca(2+)-ATPase, and cardiac calsequestrin) were down-regulated in the transgenic hearts with increased expression of calreticulin. CONCLUSIONS/SIGNIFICANCE: We show that in adult heart, up-regulated expression of calreticulin induces cardiomyopathy in vivo leading to heart failure. This is due to an alternation in changes in a subset of Ca(2+) handling genes, gap junction components and left ventricle remodeling.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2013) studied Dilated cardiomyopathy (n=33). Cardiac-specific calreticulin up-regulation vs. Control mice with tamoxifen induction was evaluated on Left ventricular ejection fraction (%EF) (p=<0.01). Cardiac-specific up-regulation of calreticulin in adult mice induced dilated cardiomyopathy, significantly reducing left ventricular ejection fraction to 30.8% compared to 64.5% in controls.
Synapse has enriched 10 related papers. Consider them for comparative context: